返回 Agenda
Leveraging Information beyond Randomised Clinical Trials: How Real World Data Can Contribute to Decision-Making
Session Chair(s)
Frank Bretz, PHD
Distinguished Quantitative Research Scientist
Novartis , Switzerland
This session reflects on how recent scientific developments are both necessitating and enabling new ways of leveraging information beyond randomised clinical trials. Robust new methods of data collection and synthesis could be adopted earlier in pharmaceutical R&D and the healthcare decision-making process through patient-level data sharing agreements and from real world data. Different approaches shall be discussed and illustrated with examples.
Speaker(s)
Threshold Crossing: A Useful Way to Establish the Counterfactual in Clinical Trials?
Franz Koenig, MSC
Medical University of Vienna, Austria
Associate Professor
Michael Krams, MD
Janssen R&D, Johnson & Johnson, United States
Vice President, Global Head of Quantitative Sciences
The Realities of Real-World Data - An HTA Perspective
Sarah Garner, PHD
World Health Organization, Denmark
Acting Program Manager, Access to Medicines and Health Products